Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
CURAGRIP is an over-the-counter herbal phytotherapy product developed by Aleonat (Laboratoires Aleonat) for the prevention and treatment of flu-like symptoms, colds, and respiratory congestion. It is formulated as a synergistic mixture of natural plant extracts and essential oils, including spirulina (*Arthrospira platensis*), white willow (*Salix alba*), echinacea (*Echinacea purpurea*), ravintsara (*Cinnamomum camphora*), and other botanical ingredients such as eucalyptus, thyme, and lavender. These components work together to provide antiviral, anti-inflammatory, and antipyretic effects, helping to relieve fever, body aches, and headaches associated with seasonal influenza.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on CURAGRIP.